Johnson & Johnson: all 3,718 studies

Page 17 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• A Study of JNJ-64251330 in Participants With Familial Adenomatous PolyposisCompletedNCT05014360Phase 1
• A Study of a Hydrocolloid Bandage on PimplesCompletedNCT05012735Phase 1
• A Study Exploring the Use of Challenge Agents in Healthy Volunteers or Participants With a Disease of InterestCompletedNCT05007756Early Phase 1
• Clinical Evaluation of Therapeutic Meibomian Gland ExpressionCompletedNCT04997135
• A Study of JNJ-78306358 in Participants With Advanced Stage Solid TumorsCompletedNCT04991740Phase 1
• A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3CompletedNCT04985955Phase 1
• A Study of JNJ-67484703 in Participants With Active Rheumatoid ArthritisCompletedNCT04985812Phase 1
• A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy ParticipantsCompletedNCT04973566Phase 1
• A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)CompletedNCT04968912Phase 2
• A Study of JNJ-73763989 in Adult Participants With Renal ImpairmentCompletedNCT04963738Phase 1
• A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical PracticeCompletedNCT04963725
• A Study of Two Macitentan Pediatric Formulations in Healthy Adult ParticipantsCompletedNCT04963439Phase 1
• A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult ParticipantsCompletedNCT04960124Phase 1
• A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) ParticipantsTerminatedNCT04955990Phase 4
• Post-market Evaluation of Clinical Outcomes in China for the TECNIS Model ZMTCompletedNCT04954898Not applicable
• A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and PsychotherapyTerminatedNCT04951609Phase 1
• A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung CancerCompletedNCT04951154
• A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion and a Lip Moisturizer in Adults of Atopic Dermatitis.WithdrawnNCT04950374Not applicable
• Post-Trial Access for Guselkumab in Participants With Familial Adenomatous PolyposisNo longer availableNCT04948398
• A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare SettingsCompletedNCT04940039Phase 4
• Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy VolunteersCompletedNCT04934124Phase 1
• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseActive, not recruitingNCT04929210Phase 4
• A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial TherapyActive, not recruitingNCT04923893Phase 3
• A Real-world Study of Cardiac Ablation for PSVT Using ST CatheterCompletedNCT04923815
• Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and PlaqueCompletedNCT04921371Phase 1
• A Study of JNJ-69095897 in Healthy ParticipantsTerminatedNCT04920578Phase 1
• A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque PsoriasisCompletedNCT04914429Phase 4
• Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's DiseaseApproved for marketingNCT04914247
• A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-70099731 in Healthy Male ParticipantsCompletedNCT04911543Phase 1
• A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate CancerActive, not recruitingNCT04898634Phase 1
• A Study of Ad26.COV2.S in Healthy Adults (COVID-19)CompletedNCT04894305Phase 1
• Clinical Investigation of Two Tecnis Investigational LensesCompletedNCT04890249Not applicable
• A Study of Nipocalimab in Adult Participants With Active Lupus NephritisWithdrawnNCT04883619Phase 2
• A Study of Nipocalimab in Adult Participants With Active Systemic Lupus ErythematosusCompletedNCT04882878Phase 2
• A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLLCompletedNCT04876092Phase 1
• Non-Invasive Assessment of Contact Lens Performance During Use of a Digital DisplayCompletedNCT04869189Not applicable
• An Observational Study of Japanese Participants With X-linked Retinitis PigmentosaCompletedNCT04868916
• A Study of JNJ-56136379 in Healthy ParticipantsWithdrawnNCT04853524Phase 1
• A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD ParticipantsTerminatedNCT04852692
• A Study of Nipocalimab in Healthy Male and Female ParticipantsCompletedNCT04848558Phase 1
• A Study of JNJ-68179280 in Healthy ParticipantsCompletedNCT04844463Phase 1
• A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795CompletedNCT04844450Phase 1
• A Study of JNJ-70033093 (Milvexian) in Healthy Adult ParticipantsCompletedNCT04844424Phase 1
• A Study of JNJ-67835989 in Healthy ParticipantsCompletedNCT04844411Phase 1
• Post-Market Clinical Follow-Up onTVT EXACT® Continence SystemActive, not recruitingNCT04829994
• A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric EmergencyWithdrawnNCT04829669
• ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)Active, not recruitingNCT04829604Phase 2
• GYNEMESH PS Mesh Post Marketing Clinical Follow-Up StudyTerminatedNCT04829058
• A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific AppendixCompletedNCT04821323Early Phase 1
• Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician UseNo longer availableNCT04817657
• A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy ParticipantsCompletedNCT04816513Phase 1
• The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity AnalyzerCompletedNCT04811079Not applicable
• Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure SystemStatus unknownNCT04807283Not applicable
• A Study of JNJ-67953964 in Healthy Japanese Adult Male ParticipantsCompletedNCT04791332Phase 1
• A Study of JNJ-70075200 in Healthy ParticipantsWithdrawnNCT04782661Phase 1
• A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT04773522Phase 1
• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular FunctionActive, not recruitingNCT04763200Not applicable
• A Twelve Week Study of Virtually Supervised Mouth Rinse and FlossingCompletedNCT04750005Phase 4
• A Study of JNJ-64304500 in Participants With Alopecia AreataWithdrawnNCT04740970Phase 2
• A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and ChildrenCompletedNCT04740892Not applicable
• A Study of JNJ-64300535 in Healthy ParticipantsCompletedNCT04736147Phase 1
• A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple MyelomaActive, not recruitingNCT04722146Phase 1
• A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed ConditionsCompletedNCT04718805Phase 1
• A Study of JNJ-61393215 in Healthy Japanese Male ParticipantsCompletedNCT04713930Phase 1
• A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult ParticipantsWithdrawnNCT04712006Phase 1
• Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With SchizophreniaCompletedNCT04709224Phase 1
• A Study of Guselkumab in Adult Participants With Celiac DiseaseWithdrawnNCT04704843Phase 1
• A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT04696809Phase 1/2
• A Twelve Week Study of Supervised Mouth Rinse and FlossingCompletedNCT04696536Phase 4
• A Study of JNJ-40411813 in Healthy Japanese Male ParticipantsCompletedNCT04677530Phase 1
• A Study to Compare Two Different Subcutaneously-administered JNJ-64304500 Formulations in Healthy ParticipantsCompletedNCT04667052Phase 1
• A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic DermatitisCompletedNCT04662619Not applicable
• ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate CancerActive, not recruitingNCT04662580Phase 1
• A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate AgentsCompletedNCT04661397Phase 1
• A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the BladderActive, not recruitingNCT04658862Phase 3
• A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT04657224Phase 1
• A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's DiseaseWithdrawnNCT04655807Phase 2
• Dynamic Characterisation of Meibomian Gland StructureCompletedNCT04649606
• Restore EF Observational StudyCompletedNCT04648306
• A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate CancerActive, not recruitingNCT04644770Phase 1
• A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseTerminatedNCT04619420Phase 2
• A Study of Intravenous Formulation of Guselkumab Using Prefilled Syringes and Final Vialed Product in Healthy ParticipantsCompletedNCT04617691Phase 1
• A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult ParticipantsCompletedNCT04616677Phase 1
• A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 2CompletedNCT04611971Phase 1
• A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)CompletedNCT04609826Phase 1
• A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid MalignanciesActive, not recruitingNCT04606381Phase 1
• Pre-Approval Access With Amivantamab (JNJ-61186372) in Participants With Metastatic Non-Small Cell Lung CancerApproved for marketingNCT04599712
• A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 1CompletedNCT04589026Phase 1
• A Study of JNJ-73763989 in Healthy Chinese Adult ParticipantsCompletedNCT04586439Phase 1
• A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT04586426Phase 1/2
• A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate CancerActive, not recruitingNCT04577833Phase 1
• A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha TherapyCompletedNCT04571697
• A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult ParticipantsCompletedNCT04569695Phase 1
• A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or SelexipagCompletedNCT04567602
• A Study of JNJ-64140284 in Healthy Male ParticipantsTerminatedNCT04566926Phase 1
• A Study of Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT04557098Phase 2
• A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate CancerActive, not recruitingNCT04557059Phase 3
• A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant WomenCompletedNCT04556526Phase 3
• A Study of Seltorexant in Healthy ParticipantsCompletedNCT04553042Phase 1
• A Study of JNJ-64251330 in Healthy ParticipantsCompletedNCT04552197Phase 1

← Johnson & Johnson overview and focus areas